genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Sepsis Study Reveals Four Subtypes, Suggests Why Some Trials Miss Mark
News
Alzheimer’s “Seeding-Prone” Beta Amyloid Structure Determined
News
Coffee Consumption Alters Microbiome and Improves Gut Motility
News
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
News
Smart Insulin for Diabetes Therapy Could Protect against Hypoglycemia
Insights
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Artificial Intelligence
Hey Google. Is This Lung Cancer?
News
Sepsis Study Reveals Four Subtypes, Suggests Why Some Trials Miss Mark
News
Coffee Consumption Alters Microbiome and Improves Gut Motility
News
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Cancer
Pancreatic Cancer
Pancreatic Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pancreatic Cancer
Pancreatic Cancer Halted in Mice Through Single Gene Deletion
Pancreatic Cancer
Pancreatic Cancer Results for Rucaparib Trial Presented at AACR Meeting Show Promise
Pancreatic Cancer
Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for Pancreatic Cancer
Pancreatic Cancer
Pancreatic Cancer Genomic Profiling Hints at More Personalized Therapy
Pancreatic Cancer
Pancreatic Cancer Drug Production by Bacteria Uncovered
Pancreatic Cancer
Pancreatic Cancer Diagnosis on the Tip of Your Tongue…Microbiome
Pancreatic Cancer
Pancreatic Cancer Immune Checkpoint Target Identified
Pancreatic Cancer
Aggressive Pancreatic Cancer Addicted to Transcription Factor
Pancreatic Cancer
Cannabis Combo Therapy Triples Pancreatic Cancer Survival Rate
Pancreatic Cancer
Pancreatic Tumors Run Hot, Cold Depending on Tumor-Cell-Intrinsic Factors
Pancreatic Cancer
Merrimack Halts Development of Pancreatic Cancer Candidate After Phase II Failure
Pancreatic Cancer
Inherited Pancreatic Cancer Gene Mutations Discovered in Patients with No Family...
Pancreatic Cancer
Lilly to Acquire Armo BioSciences for $1.6B
Pancreatic Cancer
Merck Invests $125M in Moderna in Expanded mRNA Cancer Vaccine Partnership
Pancreatic Cancer
Redx Halts Enrollment in Trial of Lead Candidate, Citing Adverse Events
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Source: Manu5 [(CC BY-SA 4.0)]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul31_2018_Wikimedia_PancreaticCancer2121981342-2-324x160.jpg "Pancreatic Cancer Immune Checkpoint Target Identified")
![Merrimack Pharmaceuticals is ending development of its pancreatic cancer candidate MM-141 (istiratumab) following its failure in a Phase II trial. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar16_2017_NIH_PancreaticCancerCells1501202401-324x160.jpg "Merrimack Halts Development of Pancreatic Cancer Candidate After Phase II Failure")
